Suppr超能文献

使用2019冠状病毒病呈阳性供体的肺进行移植是否安全?一项美国全国性分析。

Is Transplantation With Coronavirus Disease 2019-Positive Donor Lungs Safe? A US Nationwide Analysis.

作者信息

Asija Richa, Singh Ruby, Paneitz Dane C, Wolfe Stanley B, Chukwudi Chijioke, Michel Eriberto, Rabi Seyed Alireza, Langer Nathaniel B, Osho Asishana A, Ganapathi Asvin M

机构信息

Division of Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Division of Thoracic Surgery, Columbia University Irving Medical Center, New York, New York.

Division of Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

出版信息

Ann Thorac Surg. 2023 Nov;116(5):1046-1054. doi: 10.1016/j.athoracsur.2023.05.048. Epub 2023 Jul 26.

Abstract

BACKGROUND

Since the beginning of the pandemic, coronavirus disease 2019 (COVID-19) has caused debilitating lung failure in many patients. Practitioners have understandably been hesitant to use lungs from donors with COVID-19 for transplantation. This study aimed to analyze the characteristics and short-term outcomes of lung transplantation from donors with recent positive COVID-19 testing results.

METHODS

Lung transplantations performed between January 2020 and June 2022 were queried from the United Network for Organ Sharing database. Pediatric, multiorgan, and repeat lung transplantations were excluded. Propensity scoring matched recipients of lungs from donors with recent positive COVID-19 testing results to recipients of lungs from donors with negative COVID-19 testing results, and comparisons of 30-day mortality, 3-month mortality, and perioperative outcomes were performed.

RESULTS

A total of 5270 patients underwent lung transplantation during the study dates, including 51 patients who received lungs from donors with recent positive COVID-19 testing results. Forty-five recipients of lungs from donors with recent positive COVID-19 testing results were matched with 135 recipients of lungs from donors with negative COVID-19 testing results. After matching, there was no difference in 30-day (log-rank P = .42) and 3-month (log-rank P = .42) mortality. The incidence of other perioperative complications was similar between the groups.

CONCLUSIONS

The 30-day and 3-month survival outcomes were similar between recipients of lungs from donors with recent positive COVID-19 testing results and recipients of lungs from donors with negative COVID-19 testing results. This finding suggests that highly selected COVID-19-positive donors without evidence of active infection may be safely considered for lung transplantation. Further studies should explore long-term outcomes to provide reassurance about the safety of this practice.

摘要

背景

自疫情开始以来,2019冠状病毒病(COVID-19)已导致许多患者出现使人衰弱的肺衰竭。从业者对使用COVID-19检测呈阳性的供体的肺进行移植有所犹豫,这是可以理解的。本研究旨在分析近期COVID-19检测结果呈阳性的供体肺移植的特征和短期结果。

方法

从器官共享联合网络数据库中查询2020年1月至2022年6月期间进行的肺移植。排除儿科、多器官和再次肺移植。采用倾向评分匹配法,将近期COVID-19检测结果呈阳性的供体肺的受者与COVID-19检测结果呈阴性的供体肺的受者进行匹配,并比较30天死亡率、3个月死亡率和围手术期结果。

结果

在研究期间,共有5270例患者接受了肺移植,其中51例接受了近期COVID-19检测结果呈阳性的供体的肺。45例近期COVID-19检测结果呈阳性的供体肺的受者与135例COVID-19检测结果呈阴性的供体肺的受者相匹配。匹配后,30天(对数秩P = 0.42)和3个月(对数秩P = 0.42)死亡率无差异。两组围手术期其他并发症的发生率相似。

结论

近期COVID-19检测结果呈阳性的供体肺的受者与COVID-19检测结果呈阴性的供体肺的受者的30天和3个月生存结果相似。这一发现表明,对于没有活动性感染证据的经过严格筛选的COVID-19阳性供体,可以安全地考虑用于肺移植。进一步的研究应探索长期结果,以确保这种做法的安全性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验